Merz Aesthetics’ new hyaluronic acid dermal filler has gotten approval from the FDA, according to empr.com.
The new hyaluronic acid dermal filler, which is called Belotero Balance, has been approved to treat moderate to severe facial wrinkles and folds. This includes nasolabial folds, the lines that run from your nose to the edges of your mouth.
Belotero Balance joins Merz Aesthetics family of non-surgical injectables, including Radiesse. Radiesse is a popular filler comprised of calcium-based microspheres in a water gel that works to restore lost volume in the face. Though its uses are similar to Belotero Balance, the new hyaluronic acid dermal filler works differently.
Like similar hyaluronic acid dermal fillers, Restylane and Juvederm, Belotero Balance works to restore lost volume to your skin by increasing its hydration. Hyaluronic acid is a naturally occurring hydrating component in your skin and these dermal fillers work to mimic it. When injected into the skin beneath the site of a wrinkle, a hyaluronic acid dermal filler provides a sort of scaffolding for depressed areas of skin, supporting them and improving the appearance of youth on the face.
To test the effectiveness of Belotero Balance, it was compared in a split-face study with a collagen-based filler. Using a scale that rates wrinkle severity, Belotero Balance was shown to provide a greater reduction in the appearance of nasolabial folds over 24 weeks. In fact, at the six-month mark, Belotero Balance still showed a greater correction of the wrinkles than its counterpart.